Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 640

1.

The degree of inhomogeneity of the absorbed cell nucleus doses in the bronchial region of the human respiratory tract.

Füri P, Farkas Á, Madas BG, Hofmann W, Winkler-Heil R, Kudela G, Balásházy I.

Radiat Environ Biophys. 2019 Oct 5. doi: 10.1007/s00411-019-00814-0. [Epub ahead of print]

PMID:
31587107
2.

Emotional and feature-based modulation of the early posterior negativity.

Farkas AH, Oliver KI, Sabatinelli D.

Psychophysiology. 2019 Oct 1:e13484. doi: 10.1111/psyp.13484. [Epub ahead of print]

PMID:
31573679
3.

Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider.

Farkas A, Vanderberg R, Merriam S, DiNardo D.

J Womens Health (Larchmt). 2019 Sep 27. doi: 10.1089/jwh.2018.7643. [Epub ahead of print]

PMID:
31560601
4.

Mentorship of US Medical Students: a Systematic Review.

Farkas AH, Allenbaugh J, Bonifacino E, Turner R, Corbelli JA.

J Gen Intern Med. 2019 Sep 4. doi: 10.1007/s11606-019-05256-4. [Epub ahead of print]

PMID:
31485967
5.

The allelochemical tannic acid affects the locomotion and feeding behaviour of the pond snail, Lymnaea stagnalis, by inhibiting peripheral pathways.

Vehovszky Á, Horváth R, Farkas A, Győri J, Elekes K.

Invert Neurosci. 2019 Aug 22;19(3):10. doi: 10.1007/s10158-019-0229-7.

6.

Response of the neurovascular unit to brain metastatic breast cancer cells.

Haskó J, Fazakas C, Molnár K, Mészáros Á, Patai R, Szabó G, Erdélyi F, Nyúl-Tóth Á, Győri F, Kozma M, Farkas AE, Krizbai IA, Wilhelm I.

Acta Neuropathol Commun. 2019 Aug 19;7(1):133. doi: 10.1186/s40478-019-0788-1.

7.

Fast, Spectroscopy-Based Prediction of In Vitro Dissolution Profile of Extended Release Tablets Using Artificial Neural Networks.

Galata DL, Farkas A, Könyves Z, Mészáros LA, Szabó E, Csontos I, Pálos A, Marosi G, Nagy ZK, Nagy B.

Pharmaceutics. 2019 Aug 9;11(8). pii: E400. doi: 10.3390/pharmaceutics11080400.

8.

Electrospun amorphous solid dispersions of meloxicam: Influence of polymer type and downstream processing to orodispersible dosage forms.

Casian T, Borbás E, Ilyés K, Démuth B, Farkas A, Rapi Z, Bogdan C, Iurian S, Toma V, Știufiuc R, Farkas B, Balogh A, Marosi G, Tomuță I, Nagy ZK.

Int J Pharm. 2019 Oct 5;569:118593. doi: 10.1016/j.ijpharm.2019.118593. Epub 2019 Aug 6.

PMID:
31398371
9.

Scaled-Up Production and Tableting of Grindable Electrospun Fibers Containing a Protein-Type Drug.

Vass P, Hirsch E, Kóczián R, Démuth B, Farkas A, Fehér C, Szabó E, Németh Á, Andersen SK, Vigh T, Verreck G, Csontos I, Marosi G, Nagy ZK.

Pharmaceutics. 2019 Jul 11;11(7). pii: E329. doi: 10.3390/pharmaceutics11070329.

10.

Oral and Topical Sirolimus for Vascular Anomalies: a Multicentre Study and Review.

Sandbank S, Molho-Pessach V, Farkas A, Barzilai A, Greenberger S.

Acta Derm Venereol. 2019 Jul 12. doi: 10.2340/00015555-3262. [Epub ahead of print]

11.

Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer.

Wang L, Gong Y, Saci A, Szabo PM, Martini A, Necchi A, Siefker-Radtke A, Pal S, Plimack ER, Sfakianos JP, Bhardwaj N, Horowitz A, Farkas AM, Mulholland D, Fischer BS, Oh WK, Sharma P, Zhu J, Galsky MD.

Eur Urol. 2019 Jul 1. pii: S0302-2838(19)30515-9. doi: 10.1016/j.eururo.2019.06.025. [Epub ahead of print]

PMID:
31272788
12.

What Is the Effect of Body Mass Index on Subjective Outcome Following Vaginal Hysterectomy for Prolapse?

Gray T, Money-Taylor J, Li W, Farkas AG, Campbell PC, Radley SC.

Int Neurourol J. 2019 Jun;23(2):136-143. doi: 10.5213/inj.1938016.008. Epub 2019 Jun 30.

13.

Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection.

Farkas Á, Szipőcs A, Horváth A, Horváth I, Gálffy G, Varga J, Galambos K, Kugler S, Nagy A, Szalai Z.

Respir Med. 2019 Jul - Aug;154:133-140. doi: 10.1016/j.rmed.2019.06.021. Epub 2019 Jun 22.

PMID:
31252206
14.

Data fusion strategies for performance improvement of a Process Analytical Technology platform consisting of four instruments: An electrospinning case study.

Casian T, Farkas A, Ilyés K, Démuth B, Borbás E, Madarász L, Rapi Z, Farkas B, Balogh A, Domokos A, Marosi G, Tomută I, Nagy ZK.

Int J Pharm. 2019 Aug 15;567:118473. doi: 10.1016/j.ijpharm.2019.118473. Epub 2019 Jun 26.

PMID:
31252149
15.

Application of artificial neural networks for Process Analytical Technology-based dissolution testing.

Nagy B, Petra D, Galata DL, Démuth B, Borbás E, Marosi G, Nagy ZK, Farkas A.

Int J Pharm. 2019 Aug 15;567:118464. doi: 10.1016/j.ijpharm.2019.118464. Epub 2019 Jun 25.

PMID:
31252145
16.

[Multimodal imaging during lung and abdominal stereotactic ablative radiotherapy: from cine MRI through 3D/4D CBCT to intrafractional kV verification].

Kisiván K, Miovecz Á, Gugyerás D, Takács A, Farkas A, Glavák C, Kovács P, Antal G, László Z, Vallyon M, Cselik Z, Petõné Csima M, Gulybán Á, Hadjiev J, Lakosi F.

Magy Onkol. 2019 Jun 21;63(2):116-124. Epub 2019 Jan 10. Hungarian.

17.

Pulmonary Complications of Opioid Overdose Treated With Naloxone.

Farkas A, Lynch MJ, Westover R, Giles J, Siripong N, Nalatwad A, Pizon AF, Martin-Gill C.

Ann Emerg Med. 2019 Jun 7. pii: S0196-0644(19)30309-9. doi: 10.1016/j.annemergmed.2019.04.006. [Epub ahead of print]

PMID:
31182316
18.

Antibiotic resistance profiling of pathogenic Enterobacteriaceae from Cluj-Napoca, Romania.

Farkas A, Tarco E, Butiuc-Keul A.

Germs. 2019 Mar 1;9(1):17-27. doi: 10.18683/germs.2019.1153. eCollection 2019 Mar.

19.

Inline noninvasive Raman monitoring and feedback control of glucose concentration during ethanol fermentation.

Hirsch E, Pataki H, Domján J, Farkas A, Vass P, Fehér C, Barta Z, Nagy ZK, Marosi GJ, Csontos I.

Biotechnol Prog. 2019 Sep;35(5):e2848. doi: 10.1002/btpr.2848. Epub 2019 Jun 18.

PMID:
31115976
20.

Antibody-Mediated Rejection in a Multiple Lung Transplant Patient: A Case Report.

Radeczky P, Ghimessy ÁK, Farkas A, Csende K, Mészáros L, Török K, Fazekas L, Agócs L, Kocsis Á, Bartók T, Dancs T, Tóth KK, Schönauer N, Bogyó L, Bohács A, Madurka I, Elek J, Döme B, Rényi-Vámos F, Lang G, Gieszer B.

Transplant Proc. 2019 May;51(4):1296-1298. doi: 10.1016/j.transproceed.2019.03.005.

PMID:
31101218
21.

Diagnosis and Management of a De Novo Urothelial Carcinoma in a Kidney Allograft: A Case Report.

Farkas ÁZ, Török S, Kovács JB, Piros L, Végső G, Kiss G, Korda D, Bibok A, Hartmann E, Deák ÁP, Doros A.

Transplant Proc. 2019 May;51(4):1281-1285. doi: 10.1016/j.transproceed.2019.04.011.

PMID:
31101214
22.

Donation After Cardiac Death, a Possibility to Expand the Donor Pool: Review and the Hungarian Experience.

Ghimessy ÁK, Farkas A, Gieszer B, Radeczky P, Csende K, Mészáros L, Török K, Fazekas L, Agócs L, Kocsis Á, Bartók T, Dancs T, Tóth KK, Schönauer N, Madurka I, Elek J, Döme B, Rényi-Vámos F, Lang G, Taghavi S, Hötzenecker K, Klepetko W, Bogyó L.

Transplant Proc. 2019 May;51(4):1276-1280. doi: 10.1016/j.transproceed.2019.04.003. Review.

PMID:
31101213
23.

Lung Transplantation in Hungary From Cardiac Surgeons' Perspective.

Fazekas L, Ghimessy Á, Gieszer B, Radeczky P, Mészáros L, Török K, Bogyó L, Hartyánszky I, Pólos M, Daróczi L, Agócs L, Kocsis Á, Bartók T, Dancs T, Tóth KK, Schönauer N, Madurka I, Elek J, Döme B, Rényi-Vámos F, Lang G, Farkas A.

Transplant Proc. 2019 May;51(4):1263-1267. doi: 10.1016/j.transproceed.2019.04.007.

PMID:
31101211
24.

Lung Transplant Patients on Kilimanjaro.

Gieszer B, Radeczky P, Farkas A, Csende K, Mészáros L, Török K, Fazekas L, Bogyó L, Agócs L, Kocsis Á, Varga J, Bartók T, Dancs T, Kormosoi Tóth K, Schönauer N, Madurka I, Elek J, Döme B, Rényi-Vámos F, Lang G, Jaksch P, Ghimessy ÁK.

Transplant Proc. 2019 May;51(4):1258-1262. doi: 10.1016/j.transproceed.2019.04.004.

PMID:
31101210
25.

First 3 Years of the Hungarian Lung Transplantation Program.

Gieszer B, Ghimessy Á, Radeczky P, Farkas A, Csende K, Bogyó L, Fazekas L, Kovács N, Madurka I, Kocsis Á, Agócs L, Török K, Bartók T, Dancs T, Schönauer N, Tóth K, Eszes N, Bohács A, Czebe K, Csiszér E, Mihály S, Kovács L, Müller V, Elek J, Rényi-Vámos F, Lang G.

Transplant Proc. 2019 May;51(4):1254-1257. doi: 10.1016/j.transproceed.2019.04.015.

PMID:
31101209
26.

Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and in vitro-in silico lung deposition results.

Benke E, Farkas Á, Balásházy I, Szabó-Révész P, Ambrus R.

Drug Dev Ind Pharm. 2019 Aug;45(8):1369-1378. doi: 10.1080/03639045.2019.1620268. Epub 2019 Jun 4.

PMID:
31096805
27.

Long-term endurance training-induced cardiac adaptation in new rabbit and dog animal models of the human athlete's heart.

Polyák A, Kui P, Morvay N, Leprán I, Ágoston G, Varga A, Nagy N, Baczkó I, Farkas A, Papp JG, Varró A, Farkas AS.

Rev Cardiovasc Med. 2018 Dec 30;19(4):135-142. doi: 10.31083/j.rcm.2018.04.4161.

28.

Development of predictive nomograms for clinical use to quantify the risk of isolating resistance prone organisms in patients with infected foot ulcers.

Farkas A, Lin F, Bui K, Liu F, An GL, Pakholskiy A, Stavropoulos CF, Lantis JC, Yassin A.

Epidemiol Infect. 2019 Jan;147:e157. doi: 10.1017/S0950268818003667.

29.

Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors.

Hisada Y, Grover SP, Maqsood A, Houston R, Ay C, Noubouossie DF, Cooley BC, Wallén H, Key NS, Thålin C, Farkas ÁZ, Farkas VJ, Tenekedjiev K, Kolev K, Mackman N.

Haematologica. 2019 May 2. pii: haematol.2019.217083. doi: 10.3324/haematol.2019.217083. [Epub ahead of print]

30.

Mentorship of Women in Academic Medicine: a Systematic Review.

Farkas AH, Bonifacino E, Turner R, Tilstra SA, Corbelli JA.

J Gen Intern Med. 2019 Jul;34(7):1322-1329. doi: 10.1007/s11606-019-04955-2.

PMID:
31037545
31.

Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study.

Dhaese SAM, Thooft ADJ, Farkas A, Lipman J, Verstraete AG, Stove V, Roberts JA, De Waele JJ.

J Crit Care. 2019 Aug;52:75-79. doi: 10.1016/j.jcrc.2019.04.013. Epub 2019 Apr 9.

PMID:
30986758
32.

The natural history of Get3-like chaperones.

Farkas Á, De Laurentiis EI, Schwappach B.

Traffic. 2019 May;20(5):311-324. doi: 10.1111/tra.12643. Review.

33.

Simulation of Airway Deposition of an Aerosol Drug in COPD Patients.

Farkas Á, Lizal F, Jedelsky J, Elcner J, Horváth A, Jicha M.

Pharmaceutics. 2019 Apr 1;11(4). pii: E153. doi: 10.3390/pharmaceutics11040153.

34.

The Relationship between Body Fat Percentage and Some Anthropometric and Physical Fitness Characteristics in Pre- and Peripubertal Boys.

Szmodis M, Szmodis I, Farkas A, Mészáros Z, Mészáros J, Kemper HCG.

Int J Environ Res Public Health. 2019 Apr 1;16(7). pii: E1170. doi: 10.3390/ijerph16071170.

35.

Implementation of a clinical reasoning curriculum for clerkship-level medical students: a pseudo-randomized and controlled study.

Bonifacino E, Follansbee WP, Farkas AH, Jeong K, McNeil MA, DiNardo DJ.

Diagnosis (Berl). 2019 Jun 26;6(2):165-172. doi: 10.1515/dx-2018-0063.

PMID:
30920952
36.

Polymorphisms of human glucocorticoid receptor gene in systemic lupus erythematosus: a single-centre result.

Bazsó A, Szappanos Á, Rásonyi R, Nagy E, Farkas A, Várnai B, Patócs A, Kiss E, Poór G.

Clin Rheumatol. 2019 Jul;38(7):1979-1984. doi: 10.1007/s10067-019-04478-5. Epub 2019 Mar 9.

PMID:
30850964
37.

Corona alternating current electrospinning: A combined approach for increasing the productivity of electrospinning.

Farkas B, Balogh A, Cselkó R, Molnár K, Farkas A, Borbás E, Marosi G, Nagy ZK.

Int J Pharm. 2019 Apr 20;561:219-227. doi: 10.1016/j.ijpharm.2019.03.005. Epub 2019 Mar 4.

PMID:
30844423
38.

Continuous alternative to freeze drying: Manufacturing of cyclodextrin-based reconstitution powder from aqueous solution using scaled-up electrospinning.

Vass P, Démuth B, Farkas A, Hirsch E, Szabó E, Nagy B, Andersen SK, Vigh T, Verreck G, Csontos I, Marosi G, Nagy ZK.

J Control Release. 2019 Mar 28;298:120-127. doi: 10.1016/j.jconrel.2019.02.019. Epub 2019 Feb 16.

39.

Neutrophil extracellular traps in thrombi retrieved during interventional treatment of ischemic arterial diseases.

Farkas ÁZ, Farkas VJ, Gubucz I, Szabó L, Bálint K, Tenekedjiev K, Nagy AI, Sótonyi P, Hidi L, Nagy Z, Szikora I, Merkely B, Kolev K.

Thromb Res. 2019 Mar;175:46-52. doi: 10.1016/j.thromres.2019.01.006. Epub 2019 Jan 15.

PMID:
30703701
40.

Raman Spectroscopy for Process Analytical Technologies of Pharmaceutical Secondary Manufacturing.

Nagy B, Farkas A, Borbás E, Vass P, Nagy ZK, Marosi G.

AAPS PharmSciTech. 2018 Dec 17;20(1):1. doi: 10.1208/s12249-018-1201-2. Review.

PMID:
30560395
41.

Identification of COS markers specific for Thinopyrum elongatum chromosomes preliminary revealed high level of macrosyntenic relationship between the wheat and Th. elongatum genomes.

Gaál E, Valárik M, Molnár I, Farkas A, Linc G.

PLoS One. 2018 Dec 12;13(12):e0208840. doi: 10.1371/journal.pone.0208840. eCollection 2018.

42.

In Vivo Applicability of Neosartorya fischeri Antifungal Protein 2 (NFAP2) in Treatment of Vulvovaginal Candidiasis.

Kovács R, Holzknecht J, Hargitai Z, Papp C, Farkas A, Borics A, Tóth L, Váradi G, Tóth GK, Kovács I, Dubrac S, Majoros L, Marx F, Galgóczy L.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01777-18. doi: 10.1128/AAC.01777-18. Print 2019 Feb.

43.

[The start of the Hungarian lung transplantation program and the first results].

Gieszer B, Radeczky P, Ghimessy Á, Farkas A, Csende K, Bogyó L, Fazekas L, Kovács N, Madurka I, Kocsis Á, Agócs L, Török K, Bartók T, Dancs T, Schönauer N, Tóth K, Szabó J, Eszes N, Bohács A, Czebe K, Csiszér E, Mihály S, Kovács L, Müller V, Elek J, Rényi-Vámos F, Lang G.

Orv Hetil. 2018 Nov;159(46):1859-1868. doi: 10.1556/650.2018.31300. Hungarian.

PMID:
30450935
44.

Antimicrobial Activity of NCR Plant Peptides Strongly Depends on the Test Assays.

Farkas A, Pap B, Kondorosi É, Maróti G.

Front Microbiol. 2018 Oct 30;9:2600. doi: 10.3389/fmicb.2018.02600. eCollection 2018.

45.

Unusual Clinical Course and Imaging of D-Bifunctional Protein Deficiency, a Rare Leukodystrophy.

Farkas A, Al-Ramadhani R, McDonald K, Jordan M, Joyner D.

Pediatr Neurol. 2019 Jan;90:70-71. doi: 10.1016/j.pediatrneurol.2018.09.001. Epub 2018 Sep 21. No abstract available.

PMID:
30396834
46.

Neonicotinoid insecticides are potential substrates of the multixenobiotic resistance (MXR) mechanism in the non-target invertebrate, Dreissena sp.

Vehovszky Á, Farkas A, Csikós V, Székács A, Mörtl M, Győri J.

Aquat Toxicol. 2018 Dec;205:148-155. doi: 10.1016/j.aquatox.2018.10.013. Epub 2018 Oct 23.

PMID:
30384196
47.

Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models.

Dhaese SAM, Farkas A, Colin P, Lipman J, Stove V, Verstraete AG, Roberts JA, De Waele JJ.

J Antimicrob Chemother. 2019 Feb 1;74(2):432-441. doi: 10.1093/jac/dky434.

PMID:
30376103
48.

Unexpected Sequential NH3/H2O Solid/Gas Phase Ligand Exchange and Quasi-Intramolecular Self-Protonation Yield [NH4Cu(OH)MoO4], a Photocatalyst Misidentified before as (NH4)2Cu(MoO4)2.

Sajó IE, Bakos LP, Szilágyi IM, Lendvay G, Magyari J, Mohai M, Szegedi Á, Farkas A, Jánosity A, Klébert S, Kótai L.

Inorg Chem. 2018 Nov 5;57(21):13679-13692. doi: 10.1021/acs.inorgchem.8b02261. Epub 2018 Oct 15.

PMID:
30351069
49.

Investigating the potential use of an Antarctic variant of Janthinobacterium lividum for tackling antimicrobial resistance in a One Health approach.

Baricz A, Teban A, Chiriac CM, Szekeres E, Farkas A, Nica M, Dascălu A, Oprișan C, Lavin P, Coman C.

Sci Rep. 2018 Oct 15;8(1):15272. doi: 10.1038/s41598-018-33691-6.

50.

Liposarcoma of the glottis: A report of an unusual diagnosis in an unusual location.

Farkas AB, House LK, Khan M, Saad AG, Parker E, Joyner D.

Radiol Case Rep. 2018 Mar 30;13(3):631-634. doi: 10.1016/j.radcr.2018.02.029. eCollection 2018 Jun.

Supplemental Content

Loading ...
Support Center